Morgan Stanley’s Eloxx Pharmaceuticals ELOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.1M Buy
202,630
+201,086
+13,024% +$3.11M ﹤0.01% 4608
2026
Q2
$21.4K Buy
+1,544
New +$19.7K ﹤0.01% 6787

Other funds holding ELOX

Morgan Stanley's ELOX Position: Q3 2026 in Review

Morgan Stanley increased its Eloxx Pharmaceuticals (ELOX) stake by 13,024% in Q3 2026, buying an estimated $3.11M and bringing the position to 202,630 shares worth $3.1M. The position accounts for ﹤0.01% of the portfolio, ranked #4608.

Morgan Stanley first reported a position in ELOX in Q2 2026 and has held it in 2 quarters since. 20 funds tracked by Wall St. Rank hold ELOX as of Q3 2026.

  • Morgan Stanley held 202,630 shares of Eloxx Pharmaceuticals worth $3.1M as of Q3 2026.
  • Morgan Stanley bought 201,086 Eloxx Pharmaceuticals shares in Q3 2026, an estimated $3.11M.
  • Eloxx Pharmaceuticals made up ﹤0.01% of Morgan Stanley's portfolio in Q3 2026, its #4608 holding.
  • Morgan Stanley first reported a position in Eloxx Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
  • 20 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals as of Q3 2026.

Based on Morgan Stanley's 13F filing for Q3 2026, filed 13 Nov 2026.